Celltrion
068270.KS
#716
Rank
C$36.90 B
Marketcap
$169.53
Share price
0.23%
Change (1 day)
-6.19%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2023 (TTM): $4.04

According to Celltrion 's latest financial reports the company's current EPS (TTM) is $4.25. In 2022 the company made an earnings per share (EPS) of $4.14 a decrease over its 2021 EPS that were of $4.92.

EPS history for Celltrion from 2007 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$4.04-2.46%
2022$4.14-15.84%
2021$4.9212.77%
2020$4.3670.79%
2019$2.5515.63%
2018$2.21-33.13%
2017$3.30141.17%
2016$1.378.28%
2015$1.2611.28%
2014$1.1416.37%
2013$0.98-67.42%
2012$3.0084.22%
2011$1.6362.13%
2010$1.0080.61%
2009$0.56-559.63%
2008-$0.12-123.16%
2007$0.52